1. Home
  2. DNOW vs VCEL Comparison

DNOW vs VCEL Comparison

Compare DNOW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$16.72

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$44.27

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
VCEL
Founded
1862
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
DNOW
VCEL
Price
$16.72
$44.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$16.67
$57.75
AVG Volume (30 Days)
2.4M
463.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
$2,648,000,000.00
$276,259,000.00
Revenue This Year
$69.47
$19.40
Revenue Next Year
$8.01
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
25.68
16.45
52 Week Low
$10.94
$28.95
52 Week High
$17.26
$49.32

Technical Indicators

Market Signals
Indicator
DNOW
VCEL
Relative Strength Index (RSI) 78.01 47.47
Support Level $12.57 $44.26
Resistance Level $17.26 $49.04
Average True Range (ATR) 0.50 1.45
MACD 0.28 -0.47
Stochastic Oscillator 84.38 21.56

Price Performance

Historical Comparison
DNOW
VCEL

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: